UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder
UF Health has become one of only 40 VHL Alliance Clinical Care Centers in the United States.
The VHL Alliance is made up of leading healthcare organizations that specialize in treating von Hippel-Lindau (VHL) syndrome, a rare inherited disorder associated with tumors.
Hans Shuhaiber, M.D., a clinical assistant professor in the department of neurology in the UF College of Medicine and a member of the UF Health Cancer Center, said this recognition will ensure patients have access to the best treatment when they come to UF Health.
UF Researchers Seek To Build Confidence Into AI for Healthcare Under NSF Grant
A team of researchers at the University of Florida will explore ways to increase trustworthiness and interpretability of artificial machine learning in healthcare under a new $1.2 million grant from the National Science Foundation.
UF College of Medicine Announces Clinical Science and Basic Science Faculty Research Awards
Michael Okun, MD, and Jiang Bian, Ph.D., were recently announced as the winners of the 2021 College of Medicine Clinical Science Research Award and the UF College of Medicine Basic Science Research Award, respectively.
Is It Time for a New Image of Parkinson’s Disease?
In an article published in the journal JAMA Neurology, Dr. Melissa J Armstrong and Dr. Michael S Okun argue that it is ‘Time for a new image of Parkinson’s disease’ that more accurately reflects the varied experiences of the people with the condition.
The Patient Is the Sun – Michael Okun
Patients have greatly influenced Michael S. Okun, MD, in his life and in his work. As the executive director of the Norman Fixel Institute for Neurological Diseases at UF Health and a professor and chair of Neurology, Okun has seen the beauty of human interaction in medical care. In 1993, Okun was a second-year medical student […]
New Trial Drug Combination Shows Promise for Slowing Progression of ALS
A new drug combination tested in a multisite human clinical trial shows promise for slowing the progression of ALS, often called Lou Gehrig’s disease, researchers at the University of Florida and partner institutions reported in The New England Journal of Medicine. The oral drug, a combination of sodium phenylbutyrate and taurursodiol, was tested in the […]
The Importance of Blood Tests for Alzheimer’s: UF Neuroscientists Explain the Recent Findings
University of Florida neuroscientists Steven DeKosky, MD, and Todd Golde, MD, Ph.D., announced new findings on a blood test to diagnose Alzheimer’s disease at the Alzheimer’s Association International Conference on July 29, 2020. The test showed extremely high accuracy – around 90% – for detecting chemicals in the blood that are specific for Alzheimer’s. Those […]
UF Neurologists Create a New Image of Parkinson Disease
An outdated sketch from 1886 by Sir William Richard Gowers remains among the most used and viewed depictions of Parkinson disease, despite great advancements in the understanding of the neurological disorder. Now, UF neurologists Melissa Armstrong, M.D. and Michael S. Okun, M.D. have worked with a medical illustrator to create a new, more diverse representation of who is affected by […]
Research Snapshots: Drs. Ron Cohen and Vaughn Bryant
A study led by UF neuroscientists, Dr. Ron Cohen and Dr. Vaughn Bryant, published in Current HIV Research, demonstrated that individuals with past heavy alcohol use exhibit functional connectivity differences in the brain. Specifically, they showed decreased connectivity in frontoparietal networks, which play a key role in executive function, and increased connectivity to reward specific […]
COVID-19 Crisis As Catalyst for Telemedicine
The COVID-19 crisis has caused a rapid advance in the use of telemedicine for patients with neurological conditions. In a new Viewpoint article in JAMA Neurology, Michael S. Okun, M.D., chair of the department of neurology in the UF College of Medicine, and co-authors discuss the impact of this change and its potential long-term effect on […]